Metin Ozkan

7PUBLICATIONS
65CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Feb 21, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.

Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz

|Jan 28, 2026
Dynamic Immune-Nutritional Indices as Powerful Predictors of Pathological Complete Response in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Emel Mutlu Ozkan, Ibrahim Karadag, Mevlude Inanc

|Aug 30, 2022
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey.

Ahmet Özet, Faysal Dane, Nuri Faruk Aykan

|Jul 29, 2021
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer.

Atakan Topcu, Muhammed Mustafa Atci, Saban Secmeler

Pageof 2

Frequent Collaborators

4 joint publications

Emel Mutlu Ozkan

4 joint publications

Oktay Bozkurt

3 joint publications

Muhammet Cengiz

3 joint publications

Latif Karahan